Skip to main content
SpringerLink
Log in

Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI

  • Urogenital
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Ovarian cancer is the most lethal among the gynecologic malignancies with approximately 70% of patients presenting with advanced tumor stage. The prognosis of patients with ovarian cancer is directly related to the tumor stage and residual tumor burden after cytoreductive surgery. Exploratory laparotomy has been the cornerstone in the management of ovarian cancer, as it offers staging and tumor debulking. Understaging at initial laparotomy, however, is a problem in up to 30%, mainly due to insufficient technique and unexpected peritoneal spread outside the pelvis. Sites difficult to assess intraoperatively including the posterior aspect of the liver and the dome of the diaphragm can be well demonstrated with multiplanar imaging. CT and alternatively MRI have been accepted as adjunct imaging modalities for preoperative staging ovarian cancer. Of these, multidetector CT is the imaging modality of choice for staging ovarian cancer. In a multidisciplinary team approach patient management may be guided towards an individualized treatment plan. The contribution of imaging includes (1) surgery planning including referral practice, (2) selection of candidates for primary chemotherapy by demonstration of non (optimally) resectable disease, and (3) tissue sampling in peritoneal carcinomatosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Ozols RF (2005) Treatment goals in ovarian cancer. Int J Gynecol Cancer 5(suppl 1):3–11

    Article  Google Scholar 

  2. Spencer JA (2005) A multidisciplinary approach to ovarian cancer at diagnosis. BJR 78:S94–S10

    Google Scholar 

  3. Parkin DM, Bray F, Pisani F, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  4. Colombo N, Van Gorp T, Parma G et al (2006) Ovarian cancer. Crit Rev Oncol/Hematol 60:159–179

    Article  Google Scholar 

  5. Pignata S, Vermorken JB (2004) Ovarian cancer in the elderly. Crit Rev Oncol/Hematol 49:77–86

    Article  Google Scholar 

  6. Ozols RF, Schwartz PE, Eifel PJ (2001) Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. In: De Vita VT Jr, Hellman S, Rosenberg SA (eds) Cancer. Principles and practice of oncology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1597–1632

    Google Scholar 

  7. Clark TG, Stewart ME, Altmann DG et al (2001) A prognostic model for ovarian cancer. Br J Cancer 85:944–952

    Article  PubMed  CAS  Google Scholar 

  8. Holschneider CH, Berek JS (2000) Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19:3–10

    Article  PubMed  CAS  Google Scholar 

  9. Seidman JD, Russell P, Kurman RJ (2002) Surface epithelial tumors of the ovary. In: Kurman RJ (ed) Blaustein’s pathology of the female genital tract. Springer Verlag, Berlin Heidelberg New York, pp 791–904

    Google Scholar 

  10. Ries LAG, Eisner MP, Kosary CL et al (2002) SEER a cancer statistics review, 1973–1999 http://seer.cancer.gov/csr/1973-199/ Bethesda, MD: National cancer institute

  11. Berchuck A, Iversen ES, Lancaster JM et al (2005) Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin Cancer Res 11:3686–3696

    Article  PubMed  CAS  Google Scholar 

  12. Vaisbuch E, Dgani R, Ben-Arie A et al (2005) The role of laparoscopy in ovarian tumors of low malignant potential and early-stage ovarian cancer. Obstet Gynecol Surv 60:326–330

    Article  PubMed  Google Scholar 

  13. Ovarian cancer. American cancer society. http://www. cancer.org

  14. Staging announcement: FIGO cancer committee (1986) Gynecol Oncol 25:383–385

  15. Carnino F, Fuda GC, Ciccone G et al (1997) Significance of lymph node sampling in epithelial carcinoma of the ovary. Gynecol Oncol 65:467–472

    Article  PubMed  CAS  Google Scholar 

  16. Javitt MC, Fleischer AC, Andreotti RF et al (2005) Staging and Follow-up of ovarian cancer. American college of Radiology. http://www.acr.org recommendations

  17. Low RN, Duggan B, Barone RM et al (2005) Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year. Radiology 235:918–926

    Article  PubMed  Google Scholar 

  18. Forstner R, Kinkel K (2006) Adnexal masses: characterization of benign ovarian lesions. In: Hamm B, Forstner R (eds) CT and MRI of the female pelvis. Springer Verlag, Berlin Heidelberg New York, pp 195–230

    Google Scholar 

  19. Pannu H, Bristow RE, Montz FJ et al (2003) Multidetector CT of peritoneal carcinomatosis from ovarian cancer. RadioGraphics 23:687–701

    Article  PubMed  Google Scholar 

  20. Woodward PJ, Hosseinzadeh K, Saenger JS (2004) Radiologic staging of ovarian carcinoma with pathologic correlation. From the archives of the AFIP. Radiographics 24:225–246

    Article  PubMed  Google Scholar 

  21. Forstner R, Hricak H, Occhipinti K et al (1995) Ovarian cancer: staging with CT and MRI. Radiology 197:619–626

    PubMed  CAS  Google Scholar 

  22. Tempany CM, Zou KH, Silverman et al (2000) Staging of advanced ovarian cancer: comparison of imaging modalities-report from the Radiology Oncology Group. Radiology 215:761–767

    PubMed  CAS  Google Scholar 

  23. Coakley FV (2002) Staging ovarian cancer: role of imaging. Radiol Clin N Am 40:609–636

    Article  PubMed  Google Scholar 

  24. Yoshida Y, Kurokawa T, Kawahara K et al (2003) Incremental benefits of FDG Positron Emissions Tomography over CT alone for the preopetative staging of ovarian cancer. AJR 182:227–233

    Google Scholar 

  25. Forstner R (2006) CT and MRI in ovarian carcinoma. In: Hamm B, Forstner R (eds) CT and MRI of the female pelvis. Springer Verlag, Berlin Heidelberg New York, pp 231–261

    Google Scholar 

  26. Kurtz AB, Tsimikas JV, Tempany CMC et al (1999) Diagnosis and staging og ovatian cancer:comparative values of Doppler and conventional US, Ct, and MR imaging correlated with surgery and histopathologgic analysis-report of the Radiology diagnostic oncology group. Radiology 212:19–27

    PubMed  CAS  Google Scholar 

  27. Bristow RE, del Carmen GM, Pannu HK et al (2003) Clinically occult recurrent ovarial cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 90:519–528

    Article  PubMed  Google Scholar 

  28. Sironi S, Messa C, Mangili G et al (2004) Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings. Radiology 233:433–440

    Article  PubMed  Google Scholar 

  29. Ricke J, Sehouli J, Hach C et al (2003) Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer. Eur Radiol 13:943–949

    Article  PubMed  Google Scholar 

  30. Mitchell DG, Hill MC, Hill S et al (1986) Serous carcinoma of the ovary: CT identification of metastatic calcified implants. Radiology 158:649–652

    PubMed  CAS  Google Scholar 

  31. Low RN, Barone RM, Lacey C et al (1997) Peritoneal tumor: MRI with dilute oral Barium and intravenous Gadolinium-containing contrast agents compared with unenhanced MRI and CT. Radiology 204:513–520

    PubMed  CAS  Google Scholar 

  32. Brasanac D, Boricic I, Todorovic V et al (2005) Umbilical metastasis (Sister Josef’s nodule) as a first sign of disseminated ovarian carcinoma: comparative immhunohistochemical analysis and its metastases. Int J Gynecol Cancer 15:377–381

    Article  PubMed  CAS  Google Scholar 

  33. Low RN, Chen SC, Barone R et al (2003) Distinguishing benign from malignant bowel obstruction in patients with malignancy: findings at MRI. Radiology 228:157–165

    Article  PubMed  Google Scholar 

  34. Coakley FV, Choi PH, Gougoutas CA et al (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–499

    Article  PubMed  Google Scholar 

  35. Fujii S, Matsusue E, Nakanishi J et al (2006) Clinical utility of diffusion -weighted MR imaging in the diagnosis of ovarian tumor and peritoneal dissemination. RSNA abstract book p 750

  36. Chen SS, Lee L (1983) Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovary. Gynecol Oncol 16:95–100

    Article  PubMed  CAS  Google Scholar 

  37. Benedetti-Panici P, Greggi S, Maneschi F et al (1993) Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. Gynecol Oncol 51:150–154

    Article  PubMed  CAS  Google Scholar 

  38. Rockall AG, Sohaib SA, Harisinghani MK et al (2005) Diagnostic performance of nanoparticle-enhanced MRI in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 12:2813–2821

    Google Scholar 

  39. Bristow RE, Giuntoli RL, Pannu HK et al (2005) Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Gynecol Oncol 99:294–300

    Article  PubMed  Google Scholar 

  40. Aronberg DJ, Peterson RR, Glazer HS et al (1986) Superior diaphragmatic lymph nodes: CT assessment. J Comput Assist Tomogr 10:937–941

    Article  PubMed  CAS  Google Scholar 

  41. Holloway BJ, Gore ME, Hern RP et al (1997) The significance of paracardiac lymph node enlargement in ovarian cancer. Clin Radiol 52:692–69

    Google Scholar 

  42. Sirlin CB, Casola G, Brown AM et al (2001) US of blunt abdominal trauma: importance of free fluid in women of reproductive age. Radiology 219:229–235

    PubMed  CAS  Google Scholar 

  43. Shen-Gunther J, Mannel RS (2002) Ascites as a predictor of ovarian malignancy. Gynecol Oncol 87:77–83

    Article  PubMed  Google Scholar 

  44. Jacobs I, Bast RC (1989) The CA-125 tumour-associated antigen: a review of the literature. Human Reprod 4:1–12

    CAS  Google Scholar 

  45. Togashi K (2003) Ovarian cancer: the role of US, CT and MRI. Europ Radiol 13(Suppl 4):L87–L104

    Article  Google Scholar 

  46. Bohm-Velez M, Mendelson E, Bree R et al (2000) Ovarian cancer screening. American College of Radiology. ACR Appropriateness criteria. Radiology 215:861–871

    PubMed  Google Scholar 

  47. Zurawski VR, Knapp RC, Einhorn N et al (1988) An initial analysis of preoperative Ca 125 levels in patients with early stage ovarian carcinoma. Gynecol Oncol 30:7–14

    Article  PubMed  Google Scholar 

  48. Kinkel K, Ying L, Mehdizade A et al (2005) Indeterminate ovarian mass at US: incremental value of second imaging test for characterization- Meta-analysis and Bayesian Analysis. Radiology 236:85–94

    Article  PubMed  Google Scholar 

  49. Marhom E, Cohen I (2007) Fertility preservation options for women with malignancies. Obstet Gynecol Surv 62:58–72

    Article  Google Scholar 

  50. Quayyum A, Coakley FV, Westphalen AC et al (2005) Role of CT and MRI in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Gyneco Oncol 96:301–306

    Article  Google Scholar 

  51. Du Bois A, Rochon J, Lamparter C et al (2005) The quality assurance program of the AGO Organkommission OVAR QS- Ovar. Pattern of care and reality in Germany. Zentralblatt Gynäkol 127:9–17

    Article  Google Scholar 

  52. Giede KC, Kieser K, Dodge J, Rosen B (2005) Who should operate on patients with ovarian cancer. An evidence based review. Gynecol Oncol 99:447–461

    Article  PubMed  Google Scholar 

  53. Fischer D, Cordes T, Schroer A et al (2006) Die radikale Primäroperation des fortgeschrittenen Ovarialkarzinoms. Gynäkologe 39:762–767

    Article  Google Scholar 

  54. Aletti GD, Dowdi SC, Gostout BS et al (2006) Aggressive surgical effort and improved survival in advanced stage ovarian cancer. Obstet Gynecol 107:77–85

    PubMed  Google Scholar 

  55. Ansquer Y, Leblanc E, Clough K et al (2001) Neoadjuvant chemotherapy for unresectable ovarian carcinoma. Cancer 91:2329–2334

    Article  PubMed  CAS  Google Scholar 

  56. Schwartz PE, Chambers JT, Makuch R (1994) Neoadjuvant chemotherapy for advanced ovarian cancer. Gynecol Oncol 53:33–37

    Article  PubMed  CAS  Google Scholar 

  57. Bristow RE, Tomacruz RS, Armstrong DK et al (2002) Survival effects of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta analysis. J Clin Oncol 20:1248–1259

    Article  PubMed  Google Scholar 

  58. Huober J, Meyer A, Wagner U, Wallwiener D (2002) The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer. Cancer Res Clin Oncol 128:153–160

    Article  CAS  Google Scholar 

  59. Van der Burg ME (2001) Advanced ovarian cancer. Curr Treat Options Oncol 2:109–118

    Article  PubMed  Google Scholar 

  60. Nelson BE, Rosenfield AT, Schwartz PE (1993) Preoperative abdominopelvic CT prediction of optimal cytoreduction in epithelial ovarian cancer. J Clin Oncol 11:166–172

    PubMed  CAS  Google Scholar 

  61. Bristow RE, Duska LR, Lambrou NC et al (2000) A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 89:1532–1540

    Article  PubMed  CAS  Google Scholar 

  62. Spencer JA, Anderson K, Takeuchi E et al (2006) Radiological findings and image guided biopsy in women with peritoneal carcinomatosis and a history of breast cancer. ESUR abstract book p 22

  63. Spencer JA, Swift SE, Wilkinson N et al (2001) Peritoneal carcinomatosis: image guided peritoneal core biopsy for tumor type and patient management 221:173–177

  64. Hewitt MJ, Hall GD, Wilkinson N et al (2006) Image-guided biopsy in women with breast cancer presenting with peritoneal carcinomatosis. Int J Gynecol Cancer (2006) 16(Suppl 1):108–110

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsinstitut für Radiodiagnostik, Müllner Hauptstr. 48, A-5020, Salzburg, Austria

    Rosemarie Forstner

Authors
  1. Rosemarie Forstner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rosemarie Forstner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Forstner, R. Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI. Eur Radiol 17, 3223–3235 (2007). https://doi.org/10.1007/s00330-007-0736-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-007-0736-5

Keywords

Search

Navigation